Norma Hernández‐Pedro

Author

Instituto Nacional de Cancerología ORCID

Also Known As

N Hernández-Pedro, N. Hernandez- Pedro, N. Hernandez-Pedro, N. Hernández Pedro, N. Hernández-Pedro, N. Hernández‐Pedro, Norma Hernandez-Pedro, Norma HernáNdez-Pedro, Norma Hernández Pedro, Norma Hernández-Pedro

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Cancerología Instituto Nacional de Neurología y Neurocirugía Universidad Nacional Autónoma de México Instituto Nacional de Enfermedades Respiratorias Foundation for Clinical and Applied Cancer Research

About

Norma Hernández‐Pedro is an author at Instituto Nacional de Cancerología specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	208
2	Engineering	1	1	36
3	Health Sciences	1	1	24
4	Allergy	1	1	15
5	Biomedical Engineering	1	1	36

Norma Hernández‐Pedro

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma Óscar Arrieta, Feliciano Barrón, M. Salinas Padilla, JAMA Oncology	2019	181
The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis Óscar Arrieta, Bernardo Cacho‐Díaz, Daniela Morales‐Espinosa, BMC Cancer	2007	128
Randomized Phase II Trial of All-<i>Trans</i>-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non–Small-Cell Lung Cancer Óscar Arrieta, Claudia Haydée González-De la Rosa, Elena Aréchaga-Ocampo, Journal of Clinical Oncology	2010	124
Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis Óscar Arrieta, Benjamín Pineda, Patricia Guevara-Salazar, British Journal of Cancer	2008	83
Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer Óscar Arrieta, Alejandro Avilés‐Salas, Mario Orozco‐Morales, Cancer Medicine	2020	78
Retinoic acid reduces chemotherapy-induced neuropathy in an animal model and patients with lung cancer Óscar Arrieta, Norma Hernández‐Pedro, M.C. Fernández-González- Aragón, Neurology	2011	77
Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer Óscar Arrieta, Cynthia Villarreal‐Garza, Gloria Vizcaíno, Tumor Biology	2015	65
First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial Óscar Arrieta, Luis A. Medina, Enrique Estrada-Lobato, British Journal of Cancer	2012	45
Retinoic acid increases tissue and plasma contents of nerve growth factor and prevents neuropathy in diabetic mice Óscar Arrieta, Roberto García-Navarrete, Graciela Ordóñez, European Journal of Clinical Investigation	2005	41
Cytotoxicity induced by carbon nanotubes in experimental malignant glioma Samuel Romano-Feinholz, Alelí Salazar-Ramiro, Emilio Muñoz‐Sandoval, International Journal of Nanomedicine NanoparticlesNeuro-oncologyNanomedicineEngineeringGlioma	2017	36

Page 1